The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•27 February 2026•

1 min read

Novavax Shares Surge 17% After Surprise Q4 Profit and Revenue Beat

3D metallic 'PVH' text with 'CALVIN KLEIN' and 'TOMMY HILFIGER' names. Upward trend line, 'EARNINGS BEAT', 'REVENUE: +14%', and '2026 GUIDANCE' on an orange background.

Key Facts

1Novavax stock jumped 17% after reporting a surprise profit in Q4.

2Sales soared 67% year-over-year, driven by strong licensing revenues.

Novavax (NVAX) shares experienced a significant rally, jumping 17% following the release of its robust fourth-quarter financial results. The biotechnology company reported a surprise profit, defying analyst expectations and signaling a strong operational turnaround. Total revenue for the quarter soared by 67% year-over-year, primarily driven by robust licensing revenues. In addition to top-line growth, the company successfully implemented cost-reduction strategies that significantly lowered operating expenses. This combination of higher income and disciplined spending facilitated the company's swing to profitability during the period. Investors reacted positively to the improved financial health, driving renewed confidence in the company's long-term trajectory within the biotech sector.